Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/rheumatology/keu429 http://scihub22266oqcxt.onion/10.1093/rheumatology/keu429 C4334686!4334686!25406359     free     free     free       Rheumatology+(Oxford) 2015 ; 54 (3): 383-91 Nephropedia Template TP {{tp|p=25406359|t=2015. Indications for IVIG in rheumatic diseases |pdf=|usr=}}{{25406359}} gab.com Text Indications for IVIG in rheumatic diseases JO: Rheumatology (Oxford) http://www.kidney.de/pget.php?&tw=1&pmid=25406359 #FOAvip The use of IVIG to treat a wide variety of immune-driven diseases has grown rapidly, although the mechanism of action is not completely understood. Increasing demand for IVIG coupled with concerns regarding potential transmissible agents has led to worldwide supply shortages. National agencies have therefore produced guidelines for its use, with the latest England and Wales guideline being published in 2011. Due to the rarity of the rheumatic diseases, the evidence for IVIG use has been shown to be lacking in some areas and promising in others. Conditions in which IVIG has been shown to have benefit include ITP, Guillain?Barré syndrome and chronic inflammatory demyelinating polyneuropathy occurring in the context of rheumatic disease, as well as in SLE, idiopathic inflammatory myopathies and ANCA-associated vasculitides. This review looks at current IVIG use and is designed to be an aid for rheumatologists when considering the use of IVIG in clinical practice. Twit Text FOAVip Indications for IVIG in rheumatic diseases ????Rheumatology (Oxford) http://www.kidney.de/pget.php?&tw=1&pmid=25406359 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25406359 #FOAvip English Wikipedia <ref>{{Cite pmid|25406359}}</ref> Indications for IVIG in rheumatic diseases #MMPMID25406359 Mulhearn B; Bruce IN Rheumatology (Oxford) 2015[Mar]; 54 (3): 383-91 PMID25406359show ga The use of IVIG to treat a wide variety of immune-driven diseases has grown rapidly, although the mechanism of action is not completely understood. Increasing demand for IVIG coupled with concerns regarding potential transmissible agents has led to worldwide supply shortages. National agencies have therefore produced guidelines for its use, with the latest England and Wales guideline being published in 2011. Due to the rarity of the rheumatic diseases, the evidence for IVIG use has been shown to be lacking in some areas and promising in others. Conditions in which IVIG has been shown to have benefit include ITP, Guillain?Barré syndrome and chronic inflammatory demyelinating polyneuropathy occurring in the context of rheumatic disease, as well as in SLE, idiopathic inflammatory myopathies and ANCA-associated vasculitides. This review looks at current IVIG use and is designed to be an aid for rheumatologists when considering the use of IVIG in clinical practice. äIndications for IVIG in rheumatic diseases (epmc).pdf DeepDyve Pubget Overpricing